Transposon Therapeutics specializes in developing therapeutics for debilitating and life-threatening diseases.
Transposon Therapeutics has raised $22.0M in total funding. The most recent round was Grant. The last funding was announced in March 2026.
Transposon Therapeutics's investors include SV Health Investors, Canaan Partners, Advanced Research Projects Agency for Health, Alzheimer's Drug Discovery Foundation.
Transposon Therapeutics is headquartered in Westport, United States.
Transposon Therapeutics specializes in developing therapeutics for debilitating and life-threatening diseases.
Transposon Therapeutics is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Transposon Therapeutics — Funding & Investors." VCBacked, March 4, 2026, https://www.vcbacked.co/company/transposon-therapeutics. Accessed September 30, 2026.
VCBacked. (2026). Transposon Therapeutics — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/transposon-therapeutics
{{cite web |title=Transposon Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/transposon-therapeutics |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated